Ischemic heart disease is a significant clinical problem and results obtained during the previous grant period show that increased expression of specific heat shock proteins (HSP) exerts a protective effect against ischemia-reperfusion (Ism-Reper) induced myocardial injury. Important questions related to the protective effects of HSPs against Ism-Reper induced myocardial injury remain unanswered. We will determine in Aim I if small HSPs, alphaB-crystallin and HSP27, have a protective effect against Ism-Reper induced injury by themselves, in combination with each other, and with HSP70 family members. Adenoviral vectors expressing the small HSPs alphaB-crystallin and HSP27 at high levels upon infection of cardiac myocytes have been generated and show a protective effect in preliminary studies. In addition, transgenic mice expressing alphaB-crystallin and HSP27 in their hearts are available for these studies.
In Aim II we will determine the basis for protective effects of specific HSPs like the inducible HSP70 (HSP70i), the constitutive HSP70, and the small HSPs alphaB-crystallin and HSP27 against Ism-Reper induced injury especially cell death by apoptosis and necrosis and decreased myocardial function. Preliminary findings indicate that increased expression Of HSP70i has a protective effect against Ism-Reper induced apoptosis mediated cell death. Our preliminary findings using confocal microscopy showing that increased expression of small HSPs leads to protection of specific cytoskeletal structures against ischemia-induced injury will also be further explored.
In Aim III, we would like to investigate novel approaches to apply the protective effect of HSPs against Ism-Reper induced injury to the clinical situation. Our very recent findings indicate that 80-90 percent of myocytes can be infected by adenoviral vectors expressing specific HSPs after perfusion of hearts. Such hearts and myocytes or muscle strips derived from them are used to determine the dose response and time course of protective effects of specific HSPs against Ism-Reper. Results obtained from these investigations of protective effects of specific HSPs against Ism-Reper induced myocardial injury may lead in the future to new treatment strategies for ischemic heart disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL049434-13
Application #
6979809
Study Section
Special Emphasis Panel (NSS)
Program Officer
Liang, Isabella Y
Project Start
1993-12-01
Project End
2008-11-30
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
13
Fiscal Year
2006
Total Cost
$333,964
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Broome, Caroline S; Kayani, Anna C; Palomero, Jesus et al. (2006) Effect of lifelong overexpression of HSP70 in skeletal muscle on age-related oxidative stress and adaptation after nondamaging contractile activity. FASEB J 20:1549-51
Belke, Darrell D; Gloss, Bernd; Hollander, John M et al. (2006) In vivo gene delivery of HSP70i by adenovirus and adeno-associated virus preserves contractile function in mouse heart following ischemia-reperfusion. Am J Physiol Heart Circ Physiol 291:H2905-10
Chen, Yinghong; Epperson, Sara; Makhsudova, Lala et al. (2004) Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 287:H2478-86
Lin, Kurt M; Hollander, John M; Kao, Vivia Y et al. (2004) Myocyte protection by 10 kD heat shock protein (Hsp10) involves the mobile loop and attenuation of the Ras GTP-ase pathway. FASEB J 18:1004-6
Hollander, John M; Martin, Jody L; Belke, Darrell D et al. (2004) Overexpression of wild-type heat shock protein 27 and a nonphosphorylatable heat shock protein 27 mutant protects against ischemia/reperfusion injury in a transgenic mouse model. Circulation 110:3544-52
Andrews, Catherine; Ho, Peter D; Dillmann, Wolfgang H et al. (2003) The MKK6-p38 MAPK pathway prolongs the cardiac contractile calcium transient, downregulates SERCA2, and activates NF-AT. Cardiovasc Res 59:46-56
Villarreal, Francisco J; Griffin, Michael; Omens, Jeffrey et al. (2003) Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling. Circulation 108:1487-92
Hollander, John M; Lin, Kurt M; Scott, Brian T et al. (2003) Overexpression of PHGPx and HSP60/10 protects against ischemia/reoxygenation injury. Free Radic Biol Med 35:742-51
Martin, Jody L; Bluhm, Wolfgang F; He, Huaping et al. (2002) Mutation of COOH-terminal lysines in overexpressed alpha B-crystallin abrogates ischemic protection in cardiomyocytes. Am J Physiol Heart Circ Physiol 283:H85-91
Ray, P S; Martin, J L; Swanson, E A et al. (2001) Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J 15:393-402

Showing the most recent 10 out of 13 publications